SNPHF (Santen Pharmaceutical Co) Common Stock: $56 Mil (As of Mar. 2026)


SNPHF Santen Pharmaceutical Co Ltd SNPHF
81 GF Score
Price $13.05
GF Value $10.25
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Santen Pharmaceutical Co Common Stock?

Santen Pharmaceutical Co SNPHF +4.40% 81 Common Stock is $56 Mil as of Mar. 2026. GuruFocus rates SNPHF with a GF Score™ of 81/100 and a GF Value™ of $10.25 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Santen Pharmaceutical Co's quarterly common stock declined from Sep. 2025 ($60 Mil) to Dec. 2025 ($57 Mil) and declined from Dec. 2025 ($57 Mil) to Mar. 2026 ($56 Mil).

Santen Pharmaceutical Co's annual common stock increased from Mar. 2024 ($59 Mil) to Mar. 2025 ($59 Mil) but then declined from Mar. 2025 ($59 Mil) to Mar. 2026 ($56 Mil).

Santen Pharmaceutical Co Common Stock Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Common Stock Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.13 65.10 58.58 59.08 55.61

Santen Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.08 60.96 59.62 56.56 55.61
SNPHF
81GF Score
Santen Pharmaceutical Co Ltd SNPHF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $56 Mil mean?
Santen Pharmaceutical Co (SNPHF) has a Common Stock of $56 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Santen Pharmaceutical Co and its competitors.
Is Santen Pharmaceutical Co's Common Stock too high?
Santen Pharmaceutical Co's current Common Stock is $56 Mil. Overall, Santen Pharmaceutical Co has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Common Stock compare to LLY and JNJ?
Santen Pharmaceutical Co's Common Stock of $56 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Santen Pharmaceutical Co and its competitors. Santen Pharmaceutical Co's current Common Stock is $56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Santen Pharmaceutical Co (SNPHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.25, compared to a current price of $13.05 — trading 27.3% above its estimated fair value. The current Common Stock is $56 Mil. Santen Pharmaceutical Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Santen Pharmaceutical Co (SNPHF), the current Common Stock is $56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (SNPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of $13.05 is trading 27.3% above its estimated GF Value™ of $10.25. GuruFocus considers Santen Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SNPHF:

  • Common Stock: $56 Mil
  • GF Value™: $10.25 vs. price of $13.05 (27.3% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the SNPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
81GF Score

Get the complete analysis for SNPHF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.05
Price
$10.25
GF Value